Synonyms: CM-4307 | CM4307 | Sorafenib-d3 | Zepsun®
Compound class:
Synthetic organic
Comment: Donafenib (CM-4307) is a deuterated derivative of the approved multikinase inhibitor sorafenib. Like sorafenib, it is orally active. Deuteration improves the stability of drug molecules thus extending half-life and increasing systemic exposure. This means that the effective drug dose may be shifted downward, with an associated improvement in tolerability. The medical formulation is donafenib tosylate.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-(trideuteriomethyl)pyridine-2-carboxamide |
Synonyms ![]() |
CM-4307 | CM4307 | Sorafenib-d3 | Zepsun® |
Database Links ![]() |
|
CAS Registry No. | 1130115-44-4 (source: PubChem) |
ChEMBL Ligand | CHEMBL4297490 |
DrugBank Ligand | DB15414 |
GtoPdb PubChem SID | 461663386 |
PubChem CID | 25191001 |
Search Google for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |
Search Google for chemicals with the same backbone | MLDQJTXFUGDVEO |
UniChem Compound Search for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | MLDQJTXFUGDVEO-FIBGUPNXSA-N |